Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments

Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments

Background Whereas safe, curative treatments for hepatitis C virus (HCV) have been available since 2015, there are still 58 million infected persons worldwide, and global elimination may require new paradigms. We sought to understand the acceptability of approaches to long-acting HCV treatment....

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Weld, Ethel D, Astemborski, Jacqueline, Kirk, Gregory D, Sulkowski, Mark S, Katz, Stephanie, Rothman, Richard, Solomon, Sunil S, Matthews, Gail V, Hsieh, Yu Hsiang, Verma, Malvika, Traverso, Giovanni, Swindells, Susan, Owen, Andrew, Feld, Jordan, Flexner, Charles, Mehta, Shruti H, Thomas, David L
Бусад зохиолчид: Massachusetts Institute of Technology. Department of Biological Engineering
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: Oxford University Press 2024
Онлайн хандалт:https://hdl.handle.net/1721.1/155049

Интернэт

https://hdl.handle.net/1721.1/155049

Ижил төстэй зүйлс